These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 1107621)

  • 21. [Resistance of Enterobacteriaceae to antibiotics. II. R factor in Escherichia coli (study in 210 patients)].
    Turcu T
    Bacteriol Virusol Parazitol Epidemiol (Bucur); 1974 May; 19(3):241-5. PubMed ID: 4601942
    [No Abstract]   [Full Text] [Related]  

  • 22. Synergistic combinations of penicillins in the treatment of bacteriuria.
    Sabath LD; Elder HA; McCall CE; Finland M
    N Engl J Med; 1967 Aug; 277(5):232-8. PubMed ID: 4961731
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment with intravenous nalidixic acid in infections with gram negative microorganisms].
    Maqueda Sánchez S; Naranjo Gómez P; Alvarez Otero MJ; García de Lomana Oñate MT; Muñoz de la Paz MC; Sierra Barcena E
    Rev Clin Esp; 1980 Dec; 159(5):345-8. PubMed ID: 7221099
    [No Abstract]   [Full Text] [Related]  

  • 24. Septicaemia in chronic renal failure.
    Stathakis C; Michail S; Agrafiotis A; Bristogiannis G; Katopodis K; Lagouranis A; Dimarogona K; Avlami A; Vosnides G
    J Chemother; 1989 Jul; 1(4 Suppl):835-8. PubMed ID: 16312661
    [No Abstract]   [Full Text] [Related]  

  • 25. [In vitro activity of a new cephalosporin--cefoperazone--against Enterobacteriaceae and Pseudomonas aeruginosa].
    Modde H
    Schweiz Med Wochenschr; 1981 Mar; 111(10):356-8. PubMed ID: 6452690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Use of massive doses of penicillin for otogenic intracranial complications].
    Skopina EL; Rogova EG
    Vestn Otorinolaringol; 1973; 34(4):28-30. PubMed ID: 4576737
    [No Abstract]   [Full Text] [Related]  

  • 27. Sodium colistimethate (Coly-mycin).
    Med Lett Drugs Ther; 1968 Nov; 10(23):96. PubMed ID: 4307656
    [No Abstract]   [Full Text] [Related]  

  • 28. [Comparative study of the effects of meslocillin and carbenicillin in the treatment of surgical wound infection].
    Orłowski T; Lewandowski A; Kozaczek W; Fuksiewicz A
    Wiad Lek; 1981 May; 34(9):727-31. PubMed ID: 7025458
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of experimental Pseudomonas aeruginosa infection with carbenicillin and antiserum. Dose-effect relations].
    Mai K; Eckhardt R
    Arzneimittelforschung; 1972 Apr; 22(4):809-13. PubMed ID: 4626081
    [No Abstract]   [Full Text] [Related]  

  • 30. [Our experience with amikacin. Preliminary observations].
    Paradisi F; Cristiano P; Cioffi R; Sollecito A
    G Ital Chemioter; 1979; 26(1-2):57-62. PubMed ID: 554827
    [No Abstract]   [Full Text] [Related]  

  • 31. [Use of cefoperazone in patients after kidney transplantation].
    Wyzgał J; Paczek L; Kozłowska-Boszko B; Mularczyk H
    Pol Tyg Lek; 1990 Oct 1-8; 45(40-41):815-6. PubMed ID: 2128960
    [No Abstract]   [Full Text] [Related]  

  • 32. Temocillin susceptibility by BSAC methodology.
    Andrews JM; Jevons G; Walker R; Ashby J; Fraise AP
    J Antimicrob Chemother; 2007 Jul; 60(1):185-7. PubMed ID: 17550891
    [No Abstract]   [Full Text] [Related]  

  • 33. [Use of sulphamethoxazol-trimethoprim in urinary infection].
    Severo V; Azambuja A; Petrik RR; Gressler JF
    Rev Bras Med; 1971 May; 28(5):235-9. PubMed ID: 5563097
    [No Abstract]   [Full Text] [Related]  

  • 34. [Tobramycin in the chemotherapy of infections due to Enterobacteriaceae and Pyocyaneus. Some observations in gynecology and in neonatal age].
    Periti P; Lamanna A; Giusti M; Mazzezi T; Paradiso M; Senigagliesi L; Severi S; Carpi P; Carrara S; Gerli P
    G Ital Chemioter; 1973; 20(1-4):20-6. PubMed ID: 4806386
    [No Abstract]   [Full Text] [Related]  

  • 35. Intravenous sodium colistimethate therapy of urinary-tract infections: pharmacological and bacteriological studies.
    Cox CE; Harrison LH
    Antimicrob Agents Chemother (Bethesda); 1970; 10():296-302. PubMed ID: 4939736
    [No Abstract]   [Full Text] [Related]  

  • 36. [Cefotaxime in septicaemia and severe infections due to multiresistant Gram-negative bacilli (author's transl)].
    Dureux JB; Canton P; Roche G; Weber M; Gérard A
    Nouv Presse Med; 1981 Feb; 10(8):601-6. PubMed ID: 6259602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experimental infection in rabbits evoked by Pseudomonas aeruginosa, Proteus mirabilis, Escherichia coli and Klebsiella pneumoniae treated with gentamicin, amikacin and sisomicin.
    Jeljaszewicz J; Włodarczak K; Bis W; Kazanowski A; Kuzniewski P; Molska J
    Zentralbl Bakteriol A; 1980 Aug; 247(3):347-52. PubMed ID: 6999802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacological and therapeutic properties of gentamicin. Experimental studies on the effect level, excretion, stability and therapeutic indications].
    Naumann P; Auwärter W
    Arzneimittelforschung; 1968 Sep; 18(9):1119-23. PubMed ID: 4974678
    [No Abstract]   [Full Text] [Related]  

  • 39. Laboratory and clinical studies of carbenicillin against gram-negative bacilli.
    Standiford HC; Kind AC; Kirby WM
    Antimicrob Agents Chemother (Bethesda); 1968; 8():286-91. PubMed ID: 5735373
    [No Abstract]   [Full Text] [Related]  

  • 40. [Cephalexin monohydrate in pediatrics. Clinical, bacteriological experiences and the hematic, hepatic and renal tolerance in 120 children with respiratory infections].
    Albores JM; Martinez Meyer CA; Ots TP; Guilhem A; Bures OM; Mendez J; Lopez Scala Z
    Prensa Med Mex; 1970; ():100-7. PubMed ID: 4931110
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.